dc.contributor.author | Lewis, Christopher T.A. | |
dc.contributor.author | Mascall, Keith S. | |
dc.contributor.author | Wilson, Heather M. | |
dc.contributor.author | Murray, Fiona | |
dc.contributor.author | Kerr, Keith M. | |
dc.contributor.author | Gibson, George | |
dc.contributor.author | Buchan, Keith | |
dc.contributor.author | Small, Gary R. | |
dc.contributor.author | Nixon, Graeme F. | |
dc.date.accessioned | 2023-12-17T00:05:53Z | |
dc.date.available | 2023-12-17T00:05:53Z | |
dc.date.issued | 2023-01 | |
dc.identifier | 221532105 | |
dc.identifier | f5a85141-95e1-4850-8b85-a76356970041 | |
dc.identifier | 36336008 | |
dc.identifier | 85141794334 | |
dc.identifier.citation | Lewis , C T A , Mascall , K S , Wilson , H M , Murray , F , Kerr , K M , Gibson , G , Buchan , K , Small , G R & Nixon , G F 2023 , ' An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis ' , Journal of Molecular and Cellular Cardiology , vol. 174 , pp. 25-37 . https://doi.org/10.1016/j.yjmcc.2022.10.010 | en |
dc.identifier.issn | 0022-2828 | |
dc.identifier.other | unpaywall: 10.1016/j.yjmcc.2022.10.010 | |
dc.identifier.other | ORCID: /0000-0002-1407-7274/work/122953374 | |
dc.identifier.other | ORCID: /0000-0002-5572-4810/work/122953704 | |
dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/20021 | |
dc.description | Acknowledgements The authors would like to acknowledge the NHS Grampian Biorepository for their support and assistance with all immunohistochemistry. Sources of funding This work was generously funded by the British Heart Foundation, UK (FS/17/28/32807) and Grampian NHS Endowments. | en |
dc.format.extent | 12 | |
dc.format.extent | 3895756 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Molecular and Cellular Cardiology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Aortic valve stenosis | en |
dc.subject | Hypoxia | en |
dc.subject | Neovascularisation | en |
dc.subject | Angiogenesis | en |
dc.subject | R Medicine | en |
dc.subject | British Heart Foundation | en |
dc.subject | UK (FS/17/28/32807) | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R | en |
dc.title | An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Education | en |
dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.University of Aberdeen | en |
dc.contributor.institution | University of Aberdeen.Vice Principals | en |
dc.contributor.institution | University of Aberdeen.Aberdeen Cardiovascular and Diabetes Centre | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | https://doi.org/10.1016/j.yjmcc.2022.10.010 | |
dc.identifier.vol | 174 | en |